| Original language | English |
|---|---|
| Pages (from-to) | 3124-3126 |
| Number of pages | 3 |
| Journal | Allergy: European Journal of Allergy and Clinical Immunology |
| Volume | 77 |
| Issue number | 10 |
| Early online date | 2022 |
| DOIs |
|
| Publication status | Published - Oct 2022 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, No. 10, 10.2022, p. 3124-3126.
Research output: Contribution to journal › Comment/Letter to the editor › Academic
TY - JOUR
T1 - Fel d 1 surface expression on plant-made eBioparticles combines potent immune activation and hypoallergenicity
AU - Busold, Stefanie
AU - Aglas, Lorenz
AU - Menage, Charlotte
AU - Auger, Lydia
AU - Desgagnés, R. jean
AU - Faye, Loïc
AU - Fitchette, Anne-Catherine
AU - de Jong, Esther C.
AU - Martel, Caroline
AU - Stigler, Maria
AU - Catala-Stordeur, Virginie
AU - Tropper, Guy
AU - Vézina, Louis-Philippe
AU - Gomord, V. ronique
AU - Geijtenbeek, Teunis B. H.
AU - van Ree, Ronald
N1 - Funding Information: This project is embedded in the DC4Balance consortium, which was supported by Health Holland. The work of the authors has further been supported by Angany Inc. (Quebec, Canada), the Austrian Science Funds (Projects P32189), and the University of Salzburg priority program “Allergy‐Cancer‐BioNano Research Centre.” Funding Information: Stefanie Busold and Charlotte Menage received contract research funding and study material from Angany Inc. and the DC4Balance consortium. Lorenz Aglas and Maria Stigler received contract research funding and study material from Angany Inc. Louis‐P Vézina is a cofounder, board member, and CEO of Angany Inc. Lydia Auger, Réjean Desgagnés, Loïc Faye, Anne‐Catherine Fitchette, Caroline Martel, Virginie Stordeur, Guy Tropper, and Véronique Gomord are employees of Angany Inc. Esther C. de Jong and Teunis B. H. Geijtenbeek received funding from the DC4Balance consortium. Ronald van Ree received contract research funding and research material from Angany Inc. and the DC4Balance consortium and besides received consulting fees and/or speaker's fees from Angany Inc., HAL Allergy BV, and Citeq BV, ThermoFisher Scientific, Reacta Healthcare Ltd., Mission MightyMe, and AB Enzymes and has stock options from Angany Inc.
PY - 2022/10
Y1 - 2022/10
UR - http://www.scopus.com/inward/record.url?scp=85135535277&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/all.15464
DO - https://doi.org/10.1111/all.15464
M3 - Comment/Letter to the editor
C2 - 35916123
SN - 0105-4538
VL - 77
SP - 3124
EP - 3126
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
IS - 10
ER -